We are pleased to announce the awarding of the NIH R15 supplemental grant for our
research which aims to:
- develop new targeted MRI nanoparticle contrast agents for enhanced breast cancer
detection and
- design a multimodal microfluidic chip platform for screening tumor targeted MRI contrast agents.
Dr. Margaret Bennewitz (PI) and Dr. Trieu Nguyen (Co-I) are collaborating on this project, which will make use of WVU's Shared Research Facilities Cleanrooms for device fabrication.